Rapid Micro Biosystems, Inc. (RPID): Capital Expenditures
$850.0K
Year ended 2025-12-31
$336.0K
Trailing 12 months to 2026-06-30
-49.9%
3-year compound annual growth
+4.3%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $850.0K | -37.7% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $1.36M | -26.0% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $1.84M | -72.6% | 2025-02-28, From 2023-01-01 |
| 2022-12-31 | $6.74M | +109.5% | 2024-03-01, From 2022-01-01 |
| 2021-12-31 | $3.22M | +366.2% | 2023-03-10, From 2021-01-01 |
| 2020-12-31 | $690.0K | n/a | 2022-03-24, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $850.0K | -37.7% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $3.28M | -19.1% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $326.0K | +46.2% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $955.0K | +58.6% |
| Seer, Inc. (SEER) | 2025-12-31 | $1.80M | -49.9% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $1.26M | -52.4% |
| Lifeloc Technologies, Inc (LCTC) | 2025-12-31 | $462.8K | -14.3% |
| Quanterix Corp (QTRX) | 2025-12-31 | $2.61M | -22.4% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $2.71M | -56.1% |
Compare RPID, EYPT, PRPO, MASS side by side · Screen every company in Laboratory Analytical Instruments ↗